FDA official logo
GSRS logo
PFDA official logo

ZENOCUTUZUMAB

  • UNII: AE72RB1W1X
  • Preferred Substance Name: ZENOCUTUZUMAB

  • 1969309-56-5
  • BIZENGRI
  • IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTORS, HER2 AND HER3) (HUMANIZED CLONE MCLA-128 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE MCLA-128 LIGHT CHAIN, DIMER
  • MCLA128
  • MCLA-128
  • MCLA-128 (IGG1 BISPECIFIC ANTIBODY WITH ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) ACTIVITY TARGETING HER2 AND HER3 RECEPTORS.)
  • ZENOCUTUZUMAB [INN]
  • ZENOCUTUZUMAB [USAN]
  • ZENOCUTUZUMAB [WHO-DD]
  • ZENOCUTUZUMAB-ZBCO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.